Rivastigmine vs placebo
All‐cause mortality · people with delirium
Cholinesterase inhibitors (rivastigmine) showed no clear difference in mortality compared with placebo (low certainty).
1 finding from 1 review
- Cholinesterase inhibitors for the treatment of delirium in non‐ICU settings 2018 · Cochrane Headline outcomes onlyRR 0.1 [0.01, 1.56]1 study · 15 participantsLow